Fig. 4
MR-PET parameters and serum angiogenesis-related biomarkers in early- and advanced-stage non-small-cell lung carcinoma patients. Comparisons of (a) serum VEGF-A (pg/mL), (b) MR-PET derived-maximum metabolic tumor volume (MTV), and (c) MR-PET derived- kep between early- and advanced-stage non-small-cell lung carcinoma patients. P-values for statistical comparisons were obtained using the unpaired Student’s t-test